Skip to main content
Premium Trial:

Request an Annual Quote

McGill, Genome Quebec Center Lands Nearly $11M in New Funds

NEW YORK (GenomeWeb News) – The McGill University and Genome Quebec Innovation Centre in Montreal has reeled in a two-year, C$7.6 million (US$7.6 million) grant from Genome Canada to fund its operations and the services it provides to the Canadian and international scientific communities.

Awarded under Genome Canada's Science and Technology Innovation Centre Operations Support competition, the funding will be added to a C$3.3 million grant from the Ministry of Economic Development, Innovation, and Export Trade to fund its operations, Genome Quebec President and CEO Marc LePage said on Wednesday.

The center provides genomics and proteomics research facilities for genetic disease studies and it serves as a networking site for initiatives in other research areas.

"In this regard, the Centre is carrying out remarkable work in the scientific community: it is advancing knowledge in genomics and promoting cooperation between researchers in the academic and private sectors," LePage said.

He also noted that the center serves a client pool of 800 researchers annually.

"The Innovation Centre is a driving force behind the integration of genomics into many of Québec's economic sectors, such as health care, forestry, and agriculture. Its research will pave the way to major scientific and technological breakthroughs that will help meet real needs," Sam Hamad, minister of economic development, innovation and export trade and minister responsible for the Capitale-Nationale, said in a statement.

The center houses an array of 'omics technologies and services including sequencing services via seven Applied Biosystems 3730 analyzers and next-generation sequencing on Roche GS-FLX and Illumina HiSeq 2000; gene expression analysis; genotyping; bioinformatics; DNA methylation; and cytogenetics and CNV analysis.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.